Fractyl Health Statistics
Total Valuation
Fractyl Health has a market cap or net worth of $297.80 million. The enterprise value is $350.67 million.
Market Cap | 297.80M |
Enterprise Value | 350.67M |
Important Dates
The next confirmed earnings date is Monday, May 13, 2024, after market close.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Fractyl Health has 47.88 million shares outstanding.
Shares Outstanding | 47.88M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,481.69 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 2,922.25 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.19
Current Ratio | 3.19 |
Quick Ratio | 3.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -137.50% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $1,277 |
Profits Per Employee | -$1.00M |
Employee Count | 94 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 7.21 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 38.47 |
Average Volume (30 Days) | 321,452 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Fractyl Health had revenue of $120,000 and -$94.27 million in losses. Loss per share was -$45.29.
Revenue | 120,000 |
Gross Profit | 43,000 |
Operating Income | -50.84M |
Pretax Income | -77.09M |
Net Income | -94.27M |
EBITDA | -76.81M |
EBIT | -77.09M |
Loss Per Share | -$45.29 |
Balance Sheet
The company has $33.52 million in cash and $86.39 million in debt, giving a net cash position of -$52.87 million or -$1.10 per share.
Cash & Cash Equivalents | 33.52M |
Total Debt | 86.39M |
Net Cash | -52.87M |
Net Cash Per Share | -$1.10 |
Equity / Book Value | -325.06M |
Book Value Per Share | -6.79 |
Working Capital | 24.46M |
Cash Flow
In the last 12 months, operating cash flow was -$42.82 million and capital expenditures -$359,000, giving a free cash flow of -$43.18 million.
Operating Cash Flow | -42.82M |
Capital Expenditures | -359,000 |
Free Cash Flow | -43.18M |
FCF Per Share | -$20.75 |
Margins
Gross margin is 35.83%, with operating and profit margins of -42,363.33% and -78,559.17%.
Gross Margin | 35.83% |
Operating Margin | -42,363.33% |
Pretax Margin | -64,242.50% |
Profit Margin | -78,559.17% |
EBITDA Margin | -64,004.17% |
EBIT Margin | -64,242.50% |
FCF Margin | -35,985.00% |
Dividends & Yields
Fractyl Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -31.66% |
FCF Yield | -14.50% |
Analyst Forecast
The average price target for Fractyl Health is $18.00, which is 189.39% higher than the current price. The consensus rating is "Buy".
Price Target | $18.00 |
Price Target Difference | 189.39% |
Analyst Consensus | Buy |
Analyst Count | 2 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Fractyl Health has an Altman Z-Score of -7.75 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -7.75 |
Piotroski F-Score | 1 |